Compared to NC group, fasting plasma insulin level decreased significantly in T2DM group (P < 0.01) and it increased in gAd-treated group compared with T2DM group (P < 0.05) (Figure 2). This evidence concerns the gene INS and type 2 diabetes mellitus.